These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18171385)

  • 1. Progress in Parkinson's disease.
    Schapira AH
    Eur J Neurol; 2008 Jan; 15(1):1. PubMed ID: 18171385
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies.
    Sulkava R
    Adv Neurol; 2003; 91():411-3. PubMed ID: 12442700
    [No Abstract]   [Full Text] [Related]  

  • 3. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 4. Timing the initiation of treatment in Parkinson's disease.
    Grosset DG; Schapira AH
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):615. PubMed ID: 18487552
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognitive issues in Parkinson's disease.
    Elmer L
    Neurol Clin; 2004 Oct; 22(3 Suppl):S91-S106. PubMed ID: 15501368
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity.
    Aarsland D; Londos E; Ballard C
    Int Psychogeriatr; 2009 Apr; 21(2):216-9. PubMed ID: 19173762
    [No Abstract]   [Full Text] [Related]  

  • 7. [L-dopa effectiveness decreases over time. What helps Parkinson patients stay mobile?].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):10. PubMed ID: 15977622
    [No Abstract]   [Full Text] [Related]  

  • 8. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia.
    McKeith IG
    Neurol Clin; 2000 Nov; 18(4):865-902. PubMed ID: 11072265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapies for Parkinson's disease: A database analysis of patient compliance and persistence.
    Tarrants ML; Denarié MF; Castelli-Haley J; Millard J; Zhang D
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):374-83. PubMed ID: 20869623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic Parkinson's disease: practical hints for the treatment].
    Ludin HP
    Praxis (Bern 1994); 2005 Jul; 94(30-31):1147-50. PubMed ID: 16117469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disorders in Parkinson's disease.
    Larsen JP
    Adv Neurol; 2003; 91():329-34. PubMed ID: 12442690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches].
    Faludi B; Janszky J; Komoly S; Kovács N
    Orv Hetil; 2015 Jul; 156(27):1091-9. PubMed ID: 26122904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies with levodopa/carbidopa intestinal gel].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2014 Jan; 67(1-2):5-8. PubMed ID: 24654442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another connection between essential tremor and Parkinson's disease?
    Louis ED
    Eur J Neurol; 2010 Jan; 17(1):3-4. PubMed ID: 19845748
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in Parkinson's disease.
    Vécsei L
    Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK
    Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.